Bladder cancer

Immunotherapy and antibody-drug conjugates: handling AEs and special populations

View the PinPoint cases (
) and get feedback

mUCa, grade 2 pneumonitis while on IO
mUCa, platinum- and IO-refractory
mUCa, with systemic lupus
mUCa, IO stopped due to AE
mUCa, with grade 2 neuropathy
mUCa, with brain metastasis
mUCa, grade 3 pneumonitis while on IO
mUCa, with severe diabetes mellitus